Loading clinical trials...
Loading clinical trials...
Optimizing Prolonged Treatment In Myeloma Using MRD Assessment (OPTIMUM)
Conditions
Interventions
Biospecimen Collection
Bone Marrow Aspirate
+8 more
Locations
222
United States
Cancer Center at Saint Joseph's
Phoenix, Arizona, United States
CHI Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas, United States
Mission Hope Medical Oncology - Arroyo Grande
Arroyo Grande, California, United States
Pacific Central Coast Health Center-San Luis Obispo
San Luis Obispo, California, United States
Mission Hope Medical Oncology - Santa Maria
Santa Maria, California, United States
Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
Start Date
February 16, 2022
Primary Completion Date
August 6, 2023
Completion Date
January 31, 2025
Last Updated
May 23, 2025
NCT07249528
NCT06215118
NCT06679101
NCT05969860
NCT06057402
NCT06383143
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions